Drugs to Treat Alcoholism

The phrase "drugs to treat alcoholism" is a broad therapeutic functional grouping rather than a single pharmacologic class with a unified mechanism of action Agents in this category act through distinct mechanisms to support abstinence or reduce heavy consumption: disulfiram induces an aversive reaction by inhibiting aldehyde dehydrogenase, naltrexone attenuates reinforcing reward pathways by blocking opioid receptors, and acamprosate modulates glutamatergic and GABAergic neurotransmission to al...

The phrase "drugs to treat alcoholism" is a broad therapeutic functional grouping rather than a single pharmacologic class with a unified mechanism of action In clinical practice and regulatory contexts, it designates pharmacotherapies indicated as adjuncts to psychosocial support for managing alcohol use disorder (historically referred to as alcoholism or alcohol dependence)

In clinical practice and regulatory contexts, it designates pharmacotherapies indicated as adjuncts to psychosocial support for managing alcohol use disorder (historically referred to as alcoholism or alcohol dependence)

In clinical practice and regulatory contexts, it designates pharmacotherapies indicated as adjuncts to psychosocial support for managing alcohol use disorder (historically referred to as alcoholism or alcohol dependence) Agents in this category act through distinct mechanisms to support abstinence or reduce heavy consumption: disulfiram induces an aversive reaction by inhibiting aldehyde dehydrogenase, naltrexone attenuates reinforcing reward pathways by blocking opioid receptors, and acamprosat...

Agents in this category act through distinct mechanisms to support abstinence or reduce heavy consumption: disulfiram induces an aversive reaction by inhibiting aldehyde dehydrogenase, naltrexone attenuates reinforcing reward pathways by blocking opioid receptors, and acamprosate modulates glutamatergic and GABAergic neurotransmission to alleviate post-cessation neurochemical imbalances

Agents in this category act through distinct mechanisms to support abstinence or reduce heavy consumption: disulfiram induces an aversive reaction by inhibiting aldehyde dehydrogenase, naltrexone attenuates reinforcing reward pathways by blocking opioid receptors, and acamprosate modulates glutamatergic and GABAergic neurotransmission to alleviate post-cessation neurochemical imbalances